Showing results (191-200 of 197) with videos related to
Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 197 results.
Redox Biology|August 20, 2024
Carbon monoxide-loaded red blood cells ameliorate metabolic dysfunction-associated steatohepatitis progression via enhancing AMP-activated protein kinase activity and inhibiting Kupffer cell activationHiroki Yanagisawa, Hitoshi Maeda, Isamu Noguchi, et al.Pharmaceutical Research|October 21, 2024
Identification of Patients Who Require Two-Point Blood Sampling for the Peak and Trough Values Rather Than One-Point Blood Sampling for the Trough Value for the Evaluation of AUC of Vancomycin Using Bayesian EstimationAyako Suzuki, Masaru Samura, Tomoyuki Ishigo, et al.The Journal of Pharmacy and Pharmacology|June 16, 2025
Risk stratification of AUC upward deviation in patients with low serum creatinine levels treated with vancomycin: a multicenter retrospective studyTomoyuki Ishigo, Ayako Suzuki, Yuta Ibe, et al.Microbiology Spectrum|May 22, 2024
Relationship between nephrotoxicity and area under the concentration-time curve of vancomycin in critically ill patients: a multicenter retrospective studyTomoyuki Ishigo, Kazuaki Matsumoto, Hiroaki Yoshida, et al.Journal of Pharmaceutical Health Care and Sciences|March 13, 2025
Development and validation of a population pharmacokinetic model of vancomycin for patients of advanced ageKeisuke Takada, Masaru Samura, Yuki Igarashi, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 4, 2023
Flowchart for predicting achieving the target area under the concentration-time curve of vancomycin in critically ill Japanese patients: A multicenter retrospective studyTomoyuki Ishigo, Satoshi Fujii, Yuta Ibe, et al.Drug Delivery|April 25, 2018
Development of Kupffer cell targeting type-I interferon for the treatment of hepatitis via inducing anti-inflammatory and immunomodulatory actionsYuki Minayoshi, Hitoshi Maeda, Hiroki Yanagisawa, et al.Pageof 20